Ovarian cancer (OC) represents the most lethal gynecological cancer and the poor
prognosis is often attributable to late diagnosis. The diagnostic approach to woman …

Human epididymis protein 4 (HE4) is an important clinical biomarker used for the detection
of epithelial ovarian cancer (EOC). While much is known about the predictive power of HE4 …

The existence of tumor heterogeneity and complex carcinogenic mechanisms in lung
adenocarcinoma (LUAD) make the most commonly used TNM staging system unable to well …

Importance There is an urgent need to improve lung cancer risk assessment because
current screening criteria miss a large proportion of cases. Objective To investigate whether …

Introduction Since the majority of patients are diagnosed at an advanced stage, ovarian
cancer remains the most lethal gynecologic malignancy. There is no single biomarker with …

Background Non-invasive biomarkers are needed to improve management of indeterminate
pulmonary nodules (IPNs) suspicious for lung cancer. Methods Protein biomarkers were …

A delicate dual-readout immunosensor based on tetraphenylporphyrin-polymer dots (TPP-
Pdots) with brilliant photoelectrochemical and photothermal performance was first …

Objectives Among patients who underwent primary surgery for non-small cell lung cancer
(NSCLC), recurrent disease is frequent and cannot be accurately predicted solely from TNM …

Background The early diagnostic of lung cancer plays an important role in the prognosis of
surgical treatment among lung cancer patients. To evaluate the clinical application of multi …

Radon is a major cause of lung cancer (LC) deaths among non-smokers worldwide.
However, no serum biomarker for screening of LC risk in high residential radon (HRR) areas …